期刊文献+

血清肿瘤坏死因子受体-6水平对AECOPD合并呼吸衰竭患者转归的影响 被引量:12

Effect of serum tumor necrosis factor receptor-6 level on prognosis of AECOPD patients with respiratory failure
原文传递
导出
摘要 目的研究肿瘤坏死因子受体-6(TR6)[诱骗受体3(DcR3)]在慢性阻塞性肺疾病急性加重期(AECOPD)合并呼吸衰竭患者血清中的表达水平,分析其对患者预后转归的影响。方法选取本院2015年3月至2017年3月收治的AECOPD患者134例为研究对象,按照是否并发呼吸衰竭分为呼吸衰竭组65例和非呼吸衰竭组69例,另取同期在本院体检健康志愿者60例为对照组。收集研究对象血清白蛋白(ALB)、C反应蛋白(CRP)水平及第一秒用力呼吸容积占预计值百分比(FEV1%)、第一秒用力呼吸容积占用力肺活量百分比(FEV1/FVC)、动脉血氧分压(PaO2)和动脉血二氧化碳分压(PaCO2)数据,采用酶联免疫吸附法测定血清白细胞介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)、DcR3水平。结果呼吸衰竭组患者ALB、FEV1%、FEV1/FVC、PaO2水平显著低于非呼吸衰竭组和对照组(P<0.05),且非呼吸衰竭组显著低于对照组(P<0.05);呼吸衰竭组患者CRP、PaCO2、IL-8、TNF-α、DcR3水平显著高于非呼吸衰竭组和对照组(P<0.05),且非呼吸衰竭组患者CRP、IL-8、TNF-α、DcR3水平显著高于对照组(P<0.05)。高DcR3水平组生存率显著低于低DcR3水平组生存率(P<0.05)。高TNF-α、DcR3水平是影响AECOPD合并呼吸衰竭患者不良预后发生的独立危险因素(P<0.05)。结论 DcR3在AECOPD合并呼吸衰竭患者血清中高表达,是影响患者不良预后发生的独立危险因素。 Objective To study the expression of serum tumor necrosis factor receptor-6 (TR6)[decoy receptor 3 (DcR3)] in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) complicated with respiratory failure,and to analyze its influence on prognosis.Methods 134 patients with AECOPD admitted to our hospital from March 2015 to March 2017 were selected as the study subjects.According to whether or not respiratory failure occurred,they were divided into respiratory failure group (65 cases) and non-respiratory failure group (69 cases).Another 60 healthy volunteers who underwent physical examination in our hospital during the same period were selected as the control group.Serum albumin (ALB),C-reactive protein (CRP),first-second forced breathing volume (FEV1%),first-second forced breathing volume (FEV1/FVC),arterial partial oxygen pressure (PaO2) and arterial partial carbon dioxide pressure (PaCO2) were collected.Enzyme-linked immunosorbent assay (ELISA) was used to detect serum levels of interleukin-8 (IL-8),tumor necrosis factor-alpha (TNF-α) and DcR3.Results The levels of ALB,FEV1,FEV1/FVC and PaO2 in respiratory failure group were significantly lower than those in non-respiratory failure group and control group (P<0.05),and those in non-respiratory failure group were significantly lower than those in control group (P<0.05);the levels of CRP,PaCO2,IL-8,TNF-α and DcR3 in respiratory failure group were significantly higher than those in non-respiratory failure group and control group (P<0.05).The survival rate of high DcR3 level group was significantly lower than that of low DcR3 level group (P<0.05).High levels of TNF-α and DcR3 were independent risk factors for adverse prognosis of AECOPD patients with respiratory failure (P<0.05).Conclusions The high expression of DcR3 in serum of AECOPD patients with respiratory failure is an independent risk factor for adverse prognosis.
作者 刘敏 王立芹 杨茂勇 朱玉森 Liu Min;Wang Liqin;Yang Maoyong;Zhu Yusen(Department of Emergency,Liaocheng Second People′s Hospital,Liaocheng 252600,China;Department of Respiratory Medicine,Liaocheng Second People′s Hospital,Liaocheng 252600,China;Department of Gastroenterology,Liaocheng Second People′s Hospital,Liaocheng 252600,China)
出处 《中国医师杂志》 CAS 2019年第8期1181-1184,1189,共5页 Journal of Chinese Physician
关键词 肿瘤坏死因子诱骗受体 肺疾病 慢性阻塞性 呼吸功能不全 Tumor necrosis factor decoy receptors Pulmonary disease, chronic obstructive Respiratory insufficiency
  • 相关文献

参考文献11

二级参考文献75

  • 1李文珠,庄国洪,颜江华,陶惠然.作为免疫相关性疾病靶点的DcR3的研究进展[J].中国肿瘤生物治疗杂志,2006,13(1):67-69. 被引量:2
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8229
  • 3Garcia-Rio F, Miravitlles M, Soriano JB, et al. Systemic inflam- mation in chronic obstructive pulmonary disease: a population- based study [J]. Respir Res,2010,11:63. DOI: 10. 1186/1465- 9921-11-63.
  • 4Hurst JR, Perera WR, Wilkinson TM, et al. 2006. Systemic and upper and lower airway inflammation at exacerbation of chronic ob- structive pulmonary disease [ J]. Am J Respir Crit Care Med, 2006,173 ( 1 ) :71-78. DOI: 10.1164/rccm. 200505-704 OC.
  • 5Rosenberg SR, Kalhan R. 2012. Biomarkers in chronic obstruc- tive pulmonary disease[Jl. Transl Res, 2012,159(4) :228-237. DOI : 10. 1016/j. trsl. 2012.01. 019.
  • 6Miller M, Cho JY, Pham A, et al. Adiponectin and functional ad- iponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease [ J]. J Immunol, 2009, 182( 1 ) :684-691. DOI: 10. 4049/jimmunol. 182.1. 684.
  • 7Chan KH, Yeung SC, Yao TJ, et al. Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease [J]. Int J Tuberc Lung Dis, 2010, 14 (9) : 1193-1200.
  • 8Kadowaki T, Yamauchi T. Adiponectin and Adiponectin Recep- tors [J]. Endocr Rev, 2005,26(3) :439-451. DOI: 10. 1210/ er. 2005-0005.
  • 9Carolan B J, Kim YI, Williams AA, et al. The association of adi- ponectir with computed tomography phenotypes in chronic obstruc- tive pulmonary disease[ J]. Am J Respir Crit Care Meal, 2013, 188(5) :561-566. DOI: 10. l164/rccm. 201212-2299OC.
  • 10Nakanishi K, Takeda Y, Tetsumoto, et al. Involvement of endo- thelial apoptosis underlying chronic obstructive pulmonary disease- like phcnotype in adiponectin-null mice: Implications for therapy[J]. Am J Respir Crit Care Med, 2011, 183(9):1164-1175. DOI : 10.1164/rccm. 201007-1091OC.

共引文献1190

同被引文献107

引证文献12

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部